Nalbuphine Hydrochloride Injection
Product Images NDC 70069-662

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 70069-662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 01)

Chemical structure of nalbuphine hydrochloride depicted with labeled molecular bonds and functional groups, alongside HCl indicating its hydrochloride salt form.*

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 02)

Label for Nalbuphine Hydrochloride Injection 10 mg/mL in a 10 mL multiple-dose vial. The label indicates it is for intramuscular, subcutaneous, or intravenous use and is manufactured by Somerset Therapeutics, LLC. The label includes storage instructions and ingredient information, and displays the NDC 70069-661-01.*

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 03)

Nalbuphine Hydrochloride Injection 10 mg/mL (100 mg/10 mL) multiple-dose vial packaging label. Labeled for intramuscular, subcutaneous, or intravenous use. Manufactured for Somerset Therapeutics, LLC. The label includes storage instructions and a list of inactive ingredients. Features the Somerset Therapeutics logo and barcode.*

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 04)

Packaging label for Nalbuphine Hydrochloride Injection 100 mg/10 mL (10 mg/mL) by Somerset Therapeutics LLC. The label indicates the product is for intramuscular, subcutaneous, or intravenous use, supplied as 10 multiple-dose 10 mL vials. Storage instructions and preservative contents are included, with a barcode and manufacturer contact information shown.*

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 05)

Label for Nalbuphine Hydrochloride Injection 200 mg/10 mL (20 mg/mL) multiple-dose vial. Intended for intramuscular, subcutaneous, or intravenous use. Manufactured for Somerset Therapeutics, LLC. Label includes NDC 70069-662-01, storage instructions, and preservative information. Made in India.*

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 06)

Nalbuphine Hydrochloride Injection 20 mg/mL, 200 mg/10 mL multiple-dose vial carton label. The label states the product is for intramuscular, subcutaneous, or intravenous use, Rx only, NDC 70069-662-01. Manufactured by Somerset Therapeutics LLC, Somerset, NJ. Ingredients and storage instructions are also included.*

FDA Label Image

Image (D4c32b91 24cf 43f2 A1d2 0120f31bbba8 07)

Nalbuphine Hydrochloride Injection 200 mg/10 mL (20 mg/mL) multiple-dose vial label by Somerset Therapeutics, LLC. The label indicates the drug for intramuscular, subcutaneous, or intravenous use. It includes storage instructions, preservative information, and a barcode, with manufacturing by Somerset Therapeutics, LLC and product made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.